Skip to main content

Table 3 Univariate and multivariate Cox’s analyses of baseline EORTC QLQ-LC13 for overall survival stratified by surgery status

From: Quality of life predicts survival in patients with non-small cell lung cancer

Variables

Surgery (N = 162)

Non-surgery (N = 312)

N

# of death

Crude HR (95%C.I.)

Adjusted HR (95%C.I.)

N

# of death

Crude HR (95%C.I.)

Adjusted HR (95%C.I.)

QLQ-LC13

        

Dyspnoea (=0 as reference)

82

8

1.00

1.00

107

44

1.00

1.00

>0

79

26

2.03 (0.91-4.51)

1.46 (0.51-4.16)

201

120

1.32 (0.93-1.86)

1.16 (0.80-1.69)

Cough (=0 as reference)

52

10

1.00

1.00

82

43

1.00

1.00

>0

109

24

1.31 (0.63-2.75)

0.80 (0.33-1.91)

230

125

1.19 (0.84-1.69)

0.97 (0.68-1.40)

Hemoptysis (=0 as reference)

146

30

1.00

1.00

261

142

1.00

1.00

>0

15

4

2.23 (0.78-6.37)

3.01 (0.81-11.18)

50

26

1.57 (1.03-2.39)*

1.04 (0.65-1.69)

Sore Mouth (=0 as reference)

154

30

1.00

1.00

278

147

1.00

1.00

>0

7

4

3.59 (1.26-10.20)*

0.87 (0.14-5.48)

33

21

1.16 (0.73-1.84)

1.03 (0.60-1.76)

Dysphagia (=0 as reference)

144

29

1.00

1.00

257

135

1.00

1.00

>0

17

5

1.31 (0.51-3.40)

0.58 (0.15-2.27)

53

32

1.73 (1.18-2.55)**

1.06 (0.68-1.64)

Peripheral Neuropathy (=0 as reference)

108

23

1.00

1.00

213

109

1.00

1.00

>0

53

11

0.86 (0.42-1.77)

1.03 (0.41-2.59)

97

59

1.10 (0.80-1.51)

1.03 (0.73-1.46)

Hair Loss (=0 as reference)

140

29

1.00

1.00

262

137

1.00

1.00

>0

21

5

1.01 (0.39-2.62)

0.32 (0.07-1.44)

47

29

0.99 (0.66-1.47)

1.11 (0.71-1.73)

Chest Pain (=0 as reference)

107

20

1.00

1.00

183

94

1.00

1.00

>0

54

14

1.05 (0.53-2.09)

0.52 (0.21-1.32)

128

73

1.07 (0.79-1.45)

0.97 (0.70-1.34)

Pain in Arm or Shoulder (=0 as reference)

123

25

1.00

1.00

217

114

1.00

1.00

>0

37

9

0.86 (0.40-1.84)

1.19 (0.45-3.14)

93

53

1.20 (0.87-1.67)

0.96 (0.66-1.39)

Other Pain Sites (=0 as reference)

117

26

 

1.00

193

106

1.00

1.00

>0

41

7

0.60 (0.26-1.39)

0.38 (0.12-1.19)

106

53

1.02 (0.74-1.42)

0.96 (0.67-1.38)

  1. Adjusted for age, sex, cancer duration, type of cancer and clinical stage (TNM stage).
  2. *:P < 0.05, **:P < 0.01, ***:P < 0.001.